Evidence map›Paper›PMID 37376644›Full record

ReviewViruses2023

Viral Infections and Schizophrenia: A Comprehensive Review.

Ioanna Kotsiri, Panagiota Resta, Alexandros Spyrantis, Charalampos Panotopoulos, Dimitrios Chaniotis, Apostolos Beloukas, Emmanouil Magiorkinis

Open access · goldAbstract readReview
In one paragraph

Review in Viruses, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
3.5field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Review
  10. Effects of positive mGlu5 modulation on DJournal of psychopharmacology (Oxford, England) · 2025
    Article
  11. Review
  12. Article
  13. Article
  14. Observational
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Ioanna KotsiriDepartment of Internal Medicine, Asklipeion General Hospital, Voulas, 16673 Athens, Greece.
Panagiota RestaDepartment of Biomedical Sciences, University of West Attica, 12243 Athens, Greece.
Alexandros SpyrantisDepartment of Internal Medicine, Asklipeion General Hospital, Voulas, 16673 Athens, Greece.
Charalampos PanotopoulosDepartment of Clinical Cardiology, General Hospital of Kalamata, 24100 Kalamata, Greece.
Dimitrios ChaniotisDepartment of Biomedical Sciences, University of West Attica, 12243 Athens, Greece.ORCID 0000-0003-2313-1305
Apostolos BeloukasDepartment of Biomedical Sciences, University of West Attica, 12243 Athens, Greece.ORCID 0000-0001-5639-0528
Emmanouil MagiorkinisDepartment of Laboratory Medicine, Sotiria General Hospital for Chest Diseases, 11527 Athens, Greece.ORCID 0000-0001-8883-7275
University of West Attica · GRGeneral Hospital Asklepieio Voulas · GRGeneral Hospital of Drama · GRSotiria General Hospital · GR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Schizophrenia is a complex mental disorder with multiple genetic and environmental factors contributing to its pathogenesis. Viral infections have been suggested to be one of the environmental factors associated with the development of this disorder. We comprehensively review all relevant published literature focusing on the relationship between schizophrenia and various viral infections, such as influenza virus, herpes virus 1 and 2 (HSV-1 and HSV-2), cytomegalovirus (CMV), Epstein-Barr virus (EBV), retrovirus, coronavirus, and Borna virus. These viruses may interfere with the normal maturation of the brain directly or through immune-induced mediators, such as cytokines, leading to the onset of schizophrenia. Changes in the expression of critical genes and elevated levels of inflammatory cytokines have been linked to virally-induced infections and relevant immune activities in schizophrenia. Future research is necessary to understand this relationship better and provide insight into the molecular mechanisms underlying the pathophysiology of schizophrenia.

Indexed as

Epstein-Barr Virus InfectionsSchizophreniaVirus DiseasesCytomegalovirusHerpesvirus 2, HumanHerpesvirus 4, HumanHumanscongenital infectionspregnancy and viral infectionsprenatal viral infectionsschizophrenia

Identifiers

PMID37376644
PMCPMC10302918
OpenAlexW4380264050

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.